Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer.
| Autor: | Roperch, Jean-Pierre1 roperch@oncodiag.fr, Grandchamp, Bernard1, Desgrandchamps, François2, Mongiat-Artus, Pierre2, Ravery, Vincent3, Ouzaid, Idir3, Roupret, Morgan4,5,6, Phe, Véronique5, Ciofu, Calin6, Tubach, Florence7,8,9, Cussenot, Olivier4,5,6, Incitti, Roberto1,10 |
|---|---|
| Zdroj: | BMC Cancer. 9/1/2016, Vol. 16, p1-9. 9p. 1 Diagram, 4 Charts, 1 Graph. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|